Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Yan H, Zou T, Tuo Q, Xu S, Li H, Belaidi AA, Lei P
Europe Glucagon-Like Peptide-1 Agonists Industry Leaders Novo Nordisk AstraZeneca Eli lilly and Company Sanofi Pfizer *Disclaimer: Major Players sorted in no particular order Market Opportunities and Future Outlook Ongoing GLP-1 receptor agonist shortages across EU Member States, addressed through the EMA-led Medicine Shortages Steering Group recommendations, have created room for supply-chain localization and additional capacity within Europe
Victoza (liraglutide) : a once-daily injectable GLP-1 receptor agonist, also sold in a higher dose for weight loss under the brand name Saxenda
People with active cancer, untreated diabetes, certain pituitary conditions, or who are pregnant or breastfeeding should avoid these treatments
At doses approved for weight loss, Saxenda is about 50% as effective as Wegovy (semaglutide 2.4 mg SC weekly)
